Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$980.16 USD
+10.25 (1.06%)
Updated May 31, 2024 04:00 PM ET
After-Market: $980.30 +0.14 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 10.61 |
EPS Last Quarter | 9.55 |
Last EPS Surprise | -6.37% |
ABR | 1.54 |
Earnings ESP
|
1.41% |
---|---|
Current Year | 43.85 |
Next Year | 46.74 |
EPS (TTM) | 43.24 |
P/E (F1) | 22.35 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.39B | 3.62B | 13.97B | 14.99B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 3.51B | 3.78B | 14.42B | 15.63B |
Low Estimate | 3.15B | 3.36B | 13.33B | 13.96B |
Year ago Sales | 3.16B | 3.36B | 13.12B | 13.97B |
Year over Year Growth Est. | 7.35% | 7.66% | 6.51% | 7.27% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.61 | 12.22 | 43.85 | 46.74 |
# of Estimates | 10 | 9 | 12 | 11 |
Most Recent Consensus | 10.69 | 12.42 | 43.21 | 50.10 |
High Estimate | 12.66 | 14.31 | 51.53 | 55.84 |
Low Estimate | 9.27 | 10.40 | 39.87 | 41.46 |
Year ago EPS | 10.24 | 11.59 | 43.79 | 43.85 |
Year over Year Growth Est. | 3.61% | 5.44% | 0.14% | 6.57% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 4 |
Up Last 60 Days | 4 | 4 | 6 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 6 | 6 | 9 | 5 |
Down Last 60 Days | 4 | 4 | 6 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 10.61 | 12.22 | 43.85 | 46.74 |
7 Days Ago | 10.61 | 12.22 | 43.85 | 46.74 |
30 Days Ago | 11.03 | 12.38 | 45.25 | 48.12 |
60 Days Ago | 10.86 | 12.27 | 44.54 | 46.78 |
90 Days Ago | 10.86 | 12.14 | 44.36 | 46.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 10.76 | 12.45 | 44.22 | 47.10 |
Zacks Consensus Estimate | 10.61 | 12.22 | 43.85 | 46.74 |
Earnings ESP | 1.41% | 1.87% | 0.83% | 0.78% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 9.55 | 11.86 | 11.59 | 10.24 | NA |
Estimate | 10.20 | 10.43 | 10.80 | 9.92 | NA |
Difference | -0.65 | 1.43 | 0.79 | 0.32 | 0.47 |
Surprise | -6.37% | 13.71% | 7.31% | 3.23% | 4.47% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more